These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 10330699

  • 1. [AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering].
    Z Kardiol; 1999 Mar; 88(3 Suppl):1-4. PubMed ID: 10330699
    [No Abstract] [Full Text] [Related]

  • 2. Medical therapy versus revascularization: the atorvastatin versus revascularization treatment AVERT trial.
    Waters DD.
    Can J Cardiol; 2000 Jan; 16 Suppl A():11A-3A. PubMed ID: 10653925
    [Abstract] [Full Text] [Related]

  • 3. [Fluvastatin in a comparative study. Are there substance-specific differences between various CSE-inhibitors?].
    Internist (Berl); 1999 Mar; 40(3 Suppl Gibt Es):1-4. PubMed ID: 10192028
    [No Abstract] [Full Text] [Related]

  • 4. [What is new? Therapy with lipid lowering agents].
    Internist (Berl); 1997 Nov; 38(11 Suppl Therapie):1-8. PubMed ID: 9403084
    [No Abstract] [Full Text] [Related]

  • 5. Atorvastatin--a new lipid-lowering drug.
    Med Lett Drugs Ther; 1997 Mar 28; 39(997):29-31. PubMed ID: 9121394
    [No Abstract] [Full Text] [Related]

  • 6. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
    Saklamaz A, Comlekci A, Temiz A, Caliskan S, Ceylan C, Alacacioglu A, Yesil S.
    Metabolism; 2005 May 28; 54(5):677-81. PubMed ID: 15877299
    [Abstract] [Full Text] [Related]

  • 7. [AVERT [The Atorvastatin versus Revascularization Treatment]].
    Mokuno H.
    Nihon Rinsho; 2001 Mar 28; 59 Suppl 3():436-41. PubMed ID: 11347110
    [No Abstract] [Full Text] [Related]

  • 8. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group.
    Am Heart J; 2004 Sep 28; 148(3):447-55. PubMed ID: 15389231
    [Abstract] [Full Text] [Related]

  • 9. [Prevention of cardiovascular diseases: Value of CSE inhibitors in the management of lipid metabolism disorders].
    Z Kardiol; 1998 Apr 28; 87(4 Suppl Stellenwer):1-4. PubMed ID: 9618894
    [No Abstract] [Full Text] [Related]

  • 10. Coronary revascularization and aggressive lipid lowering.
    Pershad A, Kratzer S, Cooper A.
    J Invasive Cardiol; 1999 Feb 28; 11(2):87-9. PubMed ID: 10745488
    [No Abstract] [Full Text] [Related]

  • 11. Statin use in a "real-world" clinical setting: aggressive lipid lowering compared with usual care in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) trial.
    Koren MJ.
    Am J Med; 2005 Dec 28; 118 Suppl 12A():16-21. PubMed ID: 16356803
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
    Liguori E, Sarcinella R.
    Minerva Cardioangiol; 1998 Sep 28; 46(9):317-8. PubMed ID: 10021861
    [No Abstract] [Full Text] [Related]

  • 13. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
    Iovine C, Lilli S, Gentile A, Patti L, Di Marino L, Cipriano P, Riccardi G, Rivellese AA.
    Eur J Clin Invest; 2006 Aug 28; 36(8):560-5. PubMed ID: 16893378
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
    Conard SE, Bays HE, Leiter LA, Bird SR, Rubino J, Lowe RS, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2008 Dec 01; 102(11):1489-94. PubMed ID: 19026302
    [Abstract] [Full Text] [Related]

  • 15. Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia.
    Olsson AG, Istad H, Luurila O, Ose L, Stender S, Tuomilehto J, Wiklund O, Southworth H, Pears J, Wilpshaar JW, Rosuvastatin Investigators Group.
    Am Heart J; 2002 Dec 01; 144(6):1044-51. PubMed ID: 12486429
    [Abstract] [Full Text] [Related]

  • 16. Atorvastatin versus revascularization treatment (AVERT): fact or fancy?
    Singh BM, Puri S, Saucedo J, Talley JD.
    Am Heart J; 2000 Jul 01; 140(1):6-9. PubMed ID: 10874254
    [No Abstract] [Full Text] [Related]

  • 17. Reversal of atherosclerosis with aggressive lipid lowering.
    Farmer JA.
    Curr Atheroscler Rep; 2005 Mar 01; 7(2):86-7. PubMed ID: 15727721
    [No Abstract] [Full Text] [Related]

  • 18. [Effective cholesterol and triglyceride lowering with atorvastatin].
    Internist (Berl); 1996 Aug 01; 37(8 Suppl Effektive):1-8. PubMed ID: 9404527
    [No Abstract] [Full Text] [Related]

  • 19. Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial.
    Waters D.
    Eur Heart J; 2000 Jul 01; 21(13):1029-31. PubMed ID: 10843815
    [No Abstract] [Full Text] [Related]

  • 20. [Lowering cholesterol. New concepts with atorvastatin].
    Internist (Berl); 1997 Jan 01; 38(1 Suppl):1-8. PubMed ID: 9102396
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.